Skip to main content
Fig. 3 | Molecular Medicine

Fig. 3

From: Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification

Fig. 3

CCAOs demonstrate activity of diverse kinase pathways. Bar graphs displaying upstream kinases that have an average fold change > 2. A ICO (blue = higher activity) vs CCAO (red = higher activity). B HAO2 (blue = higher activity) vs CCAO2 (red = higher activity). C HAO3 (blue = higher activity) vs CCAO3 (red = higher activity). D CCAO2 (blue = higher activity) vs CCAO1 (red = higher activity). E CCAO3 (blue = higher activity) vs CCAO2 (red = higher activity). F CCAO3 (blue = higher activity) vs CCAO1 (red = higher activity)

Back to article page